Opportunity Information: Apply for PA 07 041
Apply for PA 07 041
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Image Guided Cancer Interventions (STTR R41/R42)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394 Cancer Detection and Diagnosis Research.
- This funding opportunity was created on Jan 26, 2009 and posted on Nov 8, 2006.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses.
- Foreign institutions are not eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Image Guided Cancer Interventions (STTR R41/R42) opportunity (Funding Opportunity Number PA-07-041) is a National Institutes of Health (NIH) discretionary grant program designed to push forward practical, clinically tested technologies that use medical imaging to guide cancer treatment. The central focus is on image guided interventions (IGIs), meaning systems that combine imaging with real-time monitoring and therapeutic action so clinicians can better target tumors, track what is happening during a procedure, and adjust treatment on the spot. The overall intent is not just to fund isolated components or early concepts, but to support the creation and refinement of fully integrated end-to-end systems and to generate the evidence needed to show these systems work in real clinical settings.
A major emphasis of the FOA is clinical validation. Projects are expected to move beyond bench development into clinical evaluation, where appropriate, to demonstrate performance, workflow fit, and potential impact on cancer care. Because meaningful clinical validation often requires more than one site or more than one device build, the FOA also highlights the need to develop multiple prototype integrated IGI systems when multisite testing demands it. In practice, this means the program is aimed at technologies that are mature enough to be engineered into working prototypes and then evaluated in clinical environments, rather than remaining at the level of simulations or stand-alone tools.
The funding mechanism is the Small Business Technology Transfer (STTR) program using the R41 (Phase I) and R42 (Phase II) award structure, with the option for Fast Track applications that propose a seamless Phase I-to-Phase II path. STTR is specifically intended to support research partnerships between small businesses and nonprofit research institutions such as universities, medical schools, and clinical centers, which aligns with the FOA's stated goal of encouraging collaborations among small business, large business, and academic clinical partners, as well as small business joint ventures. The announcement also notes that it runs in parallel with a scientifically similar opportunity under the SBIR program (PA-07-042, using R43/R44), which is relevant for applicants deciding whether their project and partnership model fit better under STTR or SBIR rules.
In terms of budget and project period, the FOA follows the SF424 (R&R) SBIR/STTR Application Guide and statutory guidelines, but it also states specific caps for this program. For Phase I, applicants may request up to $150,000 in total costs per year for up to two years. For Phase II, applicants may request up to three years of support at up to $1,000,000 in total costs per year when the Phase II research includes clinical evaluation. If Phase II work does not include clinical evaluation, the limit is lower, capped at $750,000 in total costs per year. These ceilings signal that NIH expects Phase II projects involving clinical studies to require substantially more resources than engineering-only development.
Eligibility is oriented toward small businesses, consistent with STTR requirements, with additional eligibility details referenced in the full announcement. A clear restriction is that foreign institutions are not eligible to apply. The opportunity does not require cost sharing or matching. The program is listed under the health and education activity area and is associated with CFDA number 93.394 (Cancer Detection and Diagnosis Research), reflecting its connection to cancer imaging and intervention research priorities.
Administratively, the FOA was posted on November 8, 2006, and uses multiple receipt dates (rather than a single deadline), with exact due dates provided in the full announcement. The archived date noted is October 2, 2009, which matters for historical context and for understanding whether an applicant should instead look for a current successor FOA if seeking active funding today. The full announcement is linked through NIH at http://grants.nih.gov/grants/guide/pa-files/PA-07-041.html, and NIH provides contact support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
In plain terms, this grant opportunity is aimed at small business-led teams that can partner effectively with research and clinical institutions to build integrated imaging-plus-therapy systems for cancer, prove they work in real clinical environments, and take concrete steps toward broader, multisite evaluation and eventual adoption in clinical practice.
Frequently Asked Questions (FAQs)
What is the name and identifier of this funding opportunity?
The opportunity is titled "Image Guided Cancer Interventions (STTR R41/R42)" and has Funding Opportunity Number (FON) PA-07-041.
Which agency sponsors this grant program?
This is a National Institutes of Health (NIH) discretionary grant program.
What is the main goal of PA-07-041?
The program is intended to advance practical, clinically tested technologies that use medical imaging to guide cancer treatment, with an emphasis on integrated systems and real-world clinical evidence.
What does "image guided interventions (IGIs)" mean in this FOA?
IGIs are systems that combine medical imaging with real-time monitoring and therapeutic action so clinicians can better target tumors, observe what is happening during a procedure, and adjust treatment in real time.
Is the FOA focused on early concepts or more mature technologies?
The FOA emphasizes projects that move beyond isolated components or early concepts. It is aimed at technologies mature enough to be engineered into working prototypes and evaluated in clinical environments, rather than remaining simulations or stand-alone tools.
How important is clinical validation under this opportunity?
Clinical validation is a major emphasis. Projects are expected, where appropriate, to move beyond bench development into clinical evaluation to demonstrate performance, workflow fit, and potential impact on cancer care.
Does the program support multisite testing and multiple prototype builds?
Yes. The FOA highlights that meaningful clinical validation may require more than one site or more than one device build, and it notes the need to develop multiple prototype integrated IGI systems when multisite testing demands it.
What funding mechanism is used (e.g., R-series)?
The funding mechanism is the Small Business Technology Transfer (STTR) program using the R41 (Phase I) and R42 (Phase II) award structure.
Is a Fast Track application option available?
Yes. The FOA allows Fast Track applications that propose a seamless Phase I-to-Phase II path.
What kind of partnerships does STTR require or encourage for this FOA?
STTR is intended to support research partnerships between small businesses and nonprofit research institutions (such as universities, medical schools, and clinical centers). This aligns with the FOA goal of encouraging collaborations among small business, large business, and academic clinical partners, as well as small business joint ventures.
Is there a related SBIR opportunity mentioned?
Yes. The announcement notes it runs in parallel with a scientifically similar SBIR opportunity: PA-07-042, which uses the R43/R44 mechanism.
Where should applicants look for application preparation rules and instructions?
The FOA follows the SF424 (R&R) SBIR/STTR Application Guide and statutory guidelines, in addition to the specific caps stated in the announcement.
What is the Phase I budget cap and project duration?
For Phase I, applicants may request up to $150,000 in total costs per year for up to two years.
What is the Phase II budget cap and project duration?
For Phase II, applicants may request up to three years of support. The cap is up to $1,000,000 in total costs per year when Phase II research includes clinical evaluation. If Phase II does not include clinical evaluation, the limit is capped at $750,000 in total costs per year.
Why is the Phase II budget higher when clinical evaluation is included?
The FOA signals that NIH expects Phase II projects involving clinical studies to require substantially more resources than engineering-only development.
Who is eligible to apply?
Eligibility is oriented toward small businesses, consistent with STTR requirements, with additional eligibility details referenced in the full announcement.
Are foreign institutions eligible to apply?
No. The FOA states that foreign institutions are not eligible to apply.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
What activity area is this program associated with?
The program is listed under the health and education activity area.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA 93.394, Cancer Detection and Diagnosis Research.
When was this FOA posted, and what does the archived date mean?
The FOA was posted on November 8, 2006. It shows an archived date of October 2, 2009, which is relevant for historical context and may indicate applicants should look for a current successor FOA if seeking active funding today.
Does this FOA have a single deadline?
No. The FOA uses multiple receipt dates rather than a single deadline, with exact due dates provided in the full announcement.
Where can the full FOA announcement be found?
The full announcement is available through NIH at http://grants.nih.gov/grants/guide/pa-files/PA-07-041.html.
Who provides help for access or linking issues related to the FOA page?
NIH provides contact support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
In practical terms, what types of projects best fit this opportunity?
The opportunity is aimed at small business-led teams that can partner with research and clinical institutions to build integrated imaging-plus-therapy systems for cancer, generate evidence they work in real clinical environments, and take steps toward broader multisite evaluation and eventual clinical adoption.
Browse more opportunities from the same category: Education Health
Next opportunity: Image Guided Cancer Interventions (SBIR R43/R44)
Previous opportunity: New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 041
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 041) also looked into and applied for these:
| Funding Opportunity |
|---|
| Image Guided Cancer Interventions (SBIR R43/R44) Apply for PA 07 042 Funding Number: PA 07 042 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Neurotechnology Research, Development, and Enhancement (STTR R41/R42) Apply for PA 07 390 Funding Number: PA 07 390 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Bioengineering Approaches to Energy Balance and Obesity (SBIR R43/R44) Apply for PA 07 435 Funding Number: PA 07 435 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Bioengineering Approaches to Energy Balance and Obesity (STTR R41/R42) Apply for PA 07 436 Funding Number: PA 07 436 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Competing Renewal Awards of SBIR Phase II Grants for Brain and Behavior Tools (R44) Apply for PA 08 056 Funding Number: PA 08 056 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| New Technologies for Transient Molecular Complex Characterization (SBIR R43/R44) Apply for PA 08 110 Funding Number: PA 08 110 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| New Technologies for Transient Molecular Complex Characterization (STTR R41/R42) Apply for PA 08 111 Funding Number: PA 08 111 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Probes and Instrumentation for Monitoring and Manipulating Nervous System Plasticity (SBIR R43/R44) Apply for PA 08 146 Funding Number: PA 08 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pharmacogenomics Research Network (U01/U19) Apply for RFA GM 10 001 Funding Number: RFA GM 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Energy Efficiency and Renewable Energy System Technology Research and Development (STTR R41/R42) Apply for PA 09 101 Funding Number: PA 09 101 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR R43/R44) Apply for PA 09 100 Funding Number: PA 09 100 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Nicotine Co Dependence (R21) Apply for PA 09 098 Funding Number: PA 09 098 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Mechanisms of Alcohol and Nicotine Co Dependence (R01) Apply for PA 09 099 Funding Number: PA 09 099 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Manufacturing Processes of Medical, Dental, and Biological Technologies (SBIR R43/R44) Apply for PA 09 113 Funding Number: PA 09 113 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Manufacturing Processes of Medical, Dental, and Biological Technologies (STTR R41/R42) Apply for PA 09 114 Funding Number: PA 09 114 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R01) Apply for PA 09 106 Funding Number: PA 09 106 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R21) Apply for PA 09 107 Funding Number: PA 09 107 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Integrative Cancer Biology Program (ICBP) Centers for Cancer Systems Biology (CCSB) (U54) Apply for RFA CA 09 011 Funding Number: RFA CA 09 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Clinical Research Curriculum Award (K30) Apply for RFA RR 09 006 Funding Number: RFA RR 09 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R01) Apply for PA 09 122 Funding Number: PA 09 122 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 041", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
